Xcout Intel
Abcam
Abcam plc is a global life sciences company that develops and distributes research reagents and tools, with its global headquarters located at the Cambridge Biomedical Campus in the United Kingdom.
Subscribe to see Abcam’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Abcam at a glance
Abcam is a biotechnology company headquartered in United Kingdom, founded in 1998. It has raised at least $21.6M across the 2 funding rounds on record. Its most recent funding round raised $800,000 in March 2020.
Abcam funding rounds
At least $21.6M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $800,000 | — | |
| — | $20.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Abcam competitors
A few of Abcam's closest competitors — see the full list of competitors and alternatives →
Biorbyt is a global provider of life science reagents, including antibodies, proteins, ELISA kits, and custom research services.
Cambridge Bioscience (formerly Stratech Scientific) is a distributor of life science research reagents, equipment, and laboratory services for the scientific community.
Antibodies.com provides life science researchers globally with primary and secondary antibodies, proteins, peptides, and ELISA kits.
Abbexa is a life science supplier providing researchers with primary and secondary antibodies, proteins, ELISA kits, and other biochemical reagents.
Applied Biological Materials Inc. (abm) is a life sciences company providing biological products such as CRISPR tools, viral vectors, and custom cell lines to researchers.
4basebio PLC, an enterprise established in 2020 and situated in Cambridge, United Kingdom, is dedicated to the entire process, from conception to delivery, of synthetic DNA and RNA products. The company also provides advanced non-viral vector solutions, with operations spanning the United States, Europe, and other international markets. Their comprehensive offerings encompass research kits, bulk enzymes, various other biological products, as well as crucial licensing and AVV manufacturing services. The company primarily caters to clients within the biotech, pharmaceutical, and contract development and manufacturing organization (CDMO) industries. Notably, the firm adopted its current name, 4basebio PLC, in July 2021, having previously been known as 4basebio UK Societas.
Get Abcam's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Abcam in Xcout Intel
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access